Home›Companies›Healthcare›ALPFA Medical

Alpfa Medical, Inc.

Develops a device to treat enlarged prostates in men.

Updated Nov 9, 2026·Latest SEC filing Sep 28, 2026·Suggest an edit

About ALPFA Medical

ALPFA Medical is a private company based in Palo Alto, California, incorporated in 2021 in Delaware. It has reported $80,268,077 raised in one offering on Form D since September 2026. Its chief executive is Allan Zingeler.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 11, 2026Sep 28, 2026$80,268,077of $100.2M target71$1.1MEquity, Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ALPFA Medical's Form D filed Sep 28, 2026.

MW
Michael Wiley
Executive officer and director
Also an executive officer and director at PFARADIGM Health.
MK
Michael Kramer
Director
Also a director at PFARADIGM Health.
DB
David Bonita
Director
Also a director at PFARADIGM Health.
AZ
Allan Zingeler
Chief Executive Officer and director
Also a chief executive officer and director at PFARADIGM Health.
RV
Raju Viswanathan
Director
Also a director at PFARADIGM Health.
RP
Rupa Patel
Executive officer
Also an executive officer at PFARADIGM Health.

Sources

  1. SECAlpfa Medical, Inc. filing history
  2. CompanyPrivacy Policy